Igarashi A, Katsunuma T, Matsumura T, Komazaki H, et al. Efficacy and safety of nemolizumab in paediatric patients aged 6-12 years with atopic dermatitis with moderate-to-severe pruritus: Results from a phase III, randomised, double-blind, placebo-controlled, multicentre study. Br J Dermatol 2023 Jul 31:ljad268. doi: 10.1093.
PMID: 37522351